Changchun Keygen Biological Products Co., Ltd. Report issue

For profit Phase 4
Founded: Changchun China (2003)
Status: Acquired by China National Biotec Group Co., Ltd (2017)

Organization Overview

First Clinical Trial
2013
NCT01815073
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree